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Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially
through induction of apoptosis with less cytotoxicity on normal
lymphocytes
T Hirano, K Abe, M Gotoh and K Oka
Department ofClinical Pharmacology, Tokyo College ofPharmacy, Hachioji, Tokyo 192-03, Japan.
Summary Certain anti-cancer agents are known to induce apoptosis in human tumour cells. However, these
agents are intrinsically cytotoxic against cells of normal tissue origin, including myelocytes and immunocytes.
Here we show that a naturally occurring flavone of citrus origin, tangeretin (5,6,7,8,4'-pentamethoxyflavone),
induces apoptosis in human promyelocytic leukaemia HL-60 cells, whereas the flavone showed no cytotoxicity
against human peripheral blood mononuclear cells (PBMCs). The growth of HL-60 cells in vitro assessed by
[3H]thymidine incorporation or tetrazolium crystal formation was strongly suppressed in the presence of
tangeretin; the IC50 values range between 0.062 and 0.173JIM. Apoptosis of HL-60 cells, assessed by cell
morphology and DNA fragmentation, was demonstrated in the presence of >2.7 pM tangeretin. Flow
cytometric analysis of tangeretin-treated HL-60 cells also demonstrated apoptotic cells with low DNA content
and showed a decrease of G1 cells and a concomitant increase of S and/or G2/M cells. Apoptosis was evident
after 24h of incubation with tangeretin, and the tangeretin effect as assessed by DNA fragmentation or
growth inhibition was significantly attenuated in the presence of Zn2+, which is known to inhibit Ca2+-
dependent endonuclease activity. Ca2+ and Mg2", in contrast, promoted the effect of tangeretin. Cyclohex-
imide significantly decreased the tangeretin effect on HL-60 cell growth, suggesting that protein synthesis is
required for flavonoid-induced apoptosis. Tangeretin showed no cytotoxicity against either HL-60 cells or
mitogen-activated PBMCs even at high concentration (27pM) as determined by a dye exclusion test.
Moreover, the flavonoid was less effective on growth of human T-lymphocytic leukaemia MOLT-4 cells or on
blastogenesis of PBMCs. These results suggest that tangeretin inhibits growth of HL-60 cells in vitro, partially
through induction of apoptosis, without causing serious side-effects on immune cells.
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Induction of apoptosis, a form of programmed cell death
(Wyllie et al., 1980), in cancer cells or malignant tissues could
be an efficient strategy for cancer chemotherapy. The apop-
totic mode involves an active participation of the affected
cells in their self-destruction cascade that culminates in DNA
degradation via endonuclease activation, nuclear disintegra-
tion and formation of 'apoptotic bodies' that involves the cell
remnants (Wyllie et al., 1980; Wyllie, 1985; Arends et al.,
1990). These apoptotic bodies are rapidly cleaned from the
local tissue by macrophages (Wyllie, 1985; Compton, 1992).
Several intrinsic or extrinsic stimuli including hyperthermia
(Barry et al., 1990), UV radiation (Servomaa and Rytomaa,
1990), certain toxins (Chang et al., 1989; Barry et al., 1990),
cytokines (Wright et al., 1992), and other chemicals
(Nicolaou et al., 1993) have been reported to induce apop-
tosis in cancer cells. Recent studies also demonstrated that
some of the anti-cancer agents can induce apoptosis in
human leukaemic cells (Bertrand et al., 1991; Dive and Hick-
mann, 1991; Hickmann, 1992; Gorczyca et al., 1993),
although these agents are known to have concomitantly
serious cytotoxicity not only to malignant cells but also to
normal tissues including myelocytes and the immune cell
system. It is possible to postulate that naturally occurring
compounds included in the diet may at least partially
regulate programmed cell death in several tissues or organs.
However, little is known about its regulation and induction
by natural compounds.
Several observations (Suolinna et al., 1975; Edwards, 1979;
Verma et al., 1988), including our findings (Hirano et al.,
1989a, 1994), suggest that naturally occurring flavonoids are
cytostatic to animal tumour models in vivo and human cancer
cells in vitro. In past aetiological studies, intake of certain
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kinds of polyhydroxyphenols, such as flavonoids or lignans
in the diet, have been correlated with low incidence of colon
cancer and breast cancer (Setchell et al., 1981; Adlercreutz et
al., 1982, 1984). Moreover, a flow cytometric analysis by
Gorczyca et al. (1993) suggested that a hydroxyisoflavone
genistein induces apoptosis in human promyelocytic HL-60
leukaemic cells. Whereas genistein is also reported to inhibit
tyrosine kinase (Akiyama et al.,1987), angiogenesis (Fotsis et
al., 1993) and cell cycle progression (Matsukawa et al., 1993),
the anti-tumour mechanism of most of the natural flavonoids
is still unclear. A recent report from Yanagihara et al. (1993)
showed that, in addition to genistein, an isoflavone biochanin
A, included in soy bean diets, induces apoptosis in human
cancer cell lines established from the gastrointestinal tract.
These observations suggest that at least some flavonoids of
diet origin may be involved in regulation of programmed
death of certain types of malignant cells.
We have examined cytostatic efficacy of several phenolic
compounds of plant origin on human cancer cell lines
(Hirano et al., 1989a, 1990, 1994). In this study, we demon-
strated for the first time that, among such compounds, a
citrus polymethoxyflavonoid tangeretin (5,6,7,8,4'-pentameth-
oxyflavone) (Nelson, 1934) efficiently induces apoptosis in
HL-60 cells, by examining the morphological features of the
apoptotic cells and DNA fragmentation. Cytotoxicity of
tangeretin against leukaemic cells and normal human lym-
phocytes, by contrast, are extremely low, and the effect of the
flavonoid on HL-60 cells was attenuated in the presence of
zinc, which is known to inactivate calcium-dependent
endonucleases (Duke et al., 1983).
Materials and methods
Materials
Tangeretin was purchased from Funacoshi (Japan). RPMI-
1640 medium and fetal bovine serum (FBS) were purchasedTangeretin induces apoptosis in HL-60 cells
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from Gibco (USA). Concanavalin A was from Seikagaku
Kogyo (Japan). MTT, trypan blue and anti-cancer agents
(doxorubicin, vincristin and actinomycin D) were obtained
from Sigma (USA). Cyclosporine was a gift from Sandoz
(Switzerland). [6-3H]Thymidine (555 GBqmmol-') was from
New England Nuclear Corporation (USA). All other agents
were of the best available grade.
Leukaemia cell culture
HL-60 cells and MOLT-4 cells were purchased from ICN
Biomedicals (Japan) and maintained in RPMI-1640 medium
containing 10% FBS supplemented with L-glutamine, 100
units ml-' penicillin and 100Itgml-' streptomycin. The
leukaemia cells were washed and resuspended in the above
medium to 2 x 104 cells ml-' in the case of HL-60 or 1 x 105
cells ml-' in the case of MOLT-4 and 200yl of this cell
suspension was placed in each well of a 96-well flat-bottom
plate (Corning, USA). The cells were incubated for 24 h at
37°C in 5% carbon dioxide/air. After incubation, 4 1l of
ethanol solution containing each amount of the agents was
added to give final concentrations of 0.0001-27 itM. Aliquots
of 4 ILI of ethanol were added into control wells. The cells
were incubated for a further 96 h in the presence of each
agent and then cell growth or viability was evaluated by
either an MTT assay procedure or [3H]thymidine incorpora-
tion as described below. Cell viability was estimated with a
dye exclusion test using trypan blue as the dye.
MTT assay
The assay was carried out according to a modified method of
Sargent and Taylor (Sargent and Taylor, 1989) as follows.
After termination of cell culture, 10 iLl of 5 mg ml-' MTT in
phosphate-buffered saline (PBS) was added to every well and
the plate reincubated at 37°C in 5% carbon dioxide/air for a
further 4 h. The plate was then centrifuged at 800 g for 5 min
to precipitate cells and formazan produced by growing cells.
Aliquots of 150pl of the supernatant were removed from
every well and 175 lI of dimethyl sulphoxide (DMSO) was
added to dissolve the formazan crystals. The plate was mixed
on a microshaker for 10 min and then read on a microplate
reader (Corona MT P-32, Corona, Japan) at 550 nm. The
dose-response curve was plotted and the concentration
which gave 50% inhibition of cell growth (IC50) was cal-
culated.
Incorporation ofthymidine
[3H]Thymidine incorporation into cell DNA was determined
96 h after addition of the flavonoid. The cells were exposed
to [3H]thymidine (18.5 KBq per well) during the last 16-20 h
of the incubation period and harvested in the same way as
lymphocyte harvesting (see below). Radioactivity incor-
porated into cells was determined.
Determination ofcell viability
The number or percentage of viable cells was determined by
staining cell populations with trypan blue (Mishell et al.,
1980). One part of 0.16% trypan blue dissolved in saline was
added to one part of the cell suspension in the culture
medium and the numbers of unstained (viable) and stained
(dead) cells were counted separately. After being stained with
trypan blue, the cells were counted within 3 min.
Lymphocyte culture
PBMCs were separated from venous blood of healthy
volunteers as described previously (Hirano et al., 1989b). The
cells were suspended in RPMI-1640 medium to a cell density
of 1 x 106 cells ml-'. Aliquots of 2001il of this suspension
were placed into each well of a 96-well flat-bottom plate
(Corning, USA). Concanavalin A was added to each well to
a final concentration of 5.0 ttg ml-'. Subsequently, 4 tl of an
ethanol solution containing each of the agents was added to
final concentrations of 0.0001-27 gM. An aliquot of 411l of
ethanol was added to a control well. The plate was incubated
for 96 h in 5% carbon dioxide/air at 37C. The cells were
pulsed with 18.5 KBq per well of [3H]thymidine for the last
16 h of incubation and then collected on glass fibre filter
paper, using a multiharvester device, and dried. The radioac-
tivity retained on the filter was further processed for liquid
scintillation counting. The mean of the counts of a triplicate
for each sample was determined. Agent concentration that
would give 50% inhibition of [3HJthymidine incorporation
(IC50) was determined from the dose-response curve.
Agarose gel electrophoresis
DNA electrophoresis was carried out according to a modified
method of Gorczyca et al. (1993). In brief, HL-60 cells
treated with an agent were collected by centrifugation,
resuspended in 0.5 ml of 45 mM Tris-borate buffer-l mM
EDTA, pH 8.0 and lysed with the same buffer containing
0.25% NP-40 (Sigma, USA) and 0.1% RNase A (Sigma) for
30 min at 37°C. The lysate was further treated with
1 mgml-' of proteinase K (Sigma) for 30 min at 37°C and
then 0.1 ml of loading buffer containing 0.25% bromophenol
blue, 0.25% xylene cyanol FF and 30% glycerol was added.
An aliquot (10-20ftl) of this solution was transferred to a
1.0% agarose gel containing 0.5 pg ml-' of ethidium bromide
(Sigma) and electrophoresis was carried out at 2 V cm' for
3 h. The DNA in gels was visualised under UV light.
Flow cytometric analysis ofHL-60 cells
Cells incubated in the presence or absence of tangeretin for 4
days were washed and resuspended in 0.IM Tris-HCI, pH 7.2,
containing 1 mg ml-1 of RNase A (Sigma) to a cell density of
1 x 106 cellsml1. Then, the cell suspension was incubated
for 20 min at 37°C. The cells were washed, resuspended in
Tris-buffer containing 10 gAgml-' of ethidium bromide and
stained for 20 min. The stained cells were subsequently
analysed using a FCS-1B (Jasco, Japan) flow cytometer. An
FCS-1 System, Ver5.02 (P, Nu), software program (Jasco,
Japan) was used for the acquisition and analysis of data.
Statistics
Statistical analysis of the data was carried out by Student's
t-tests. P-values less than 0.05 were considered to be
significant.
Results
Morphological changes oftangeretin-treated HL-60 cells
Several observations have suggested that natural flavonoids
have growth-inhibitory effects on various kinds of cancer
cells (Suolinna et al., 1975; Edwards, 1979; Verma et al.,
1988; Hirano et al., 1989a, 1994). According to recent reports
(Gorczyca et al., 1993; Yanagihara et al., 1993), it is possible
to postulate that these natural compounds contained in the
diet may regulate tumorigenesis and/or growth of cancer cells
via induction of apoptosis in malignant cells. To test this
possibility, initial experiments were performed to determine if
we could visualise apoptosis in flavonoid-treated HL-60 cells
by light microscopy. Among the various natural flavonoids
(Hirano et al., 1994) examined, a citrus flavone tangeretin
(Figure 1) efficiently induced apoptotic morphological
changes in HL-60 cells. Untreated cells exhibit typical non-
adherent, fairly round morphology until 96 h of culture as
shown in Figure 2. After 24 h or more of incubation with
2.7 jLM tangeretin, some of the cells still appeared normal,
whereas others exhibited dramatic morphological alteration
characteristics to apoptosis (Wright et al., 1992) (Figure 2).
Numerous apoptotic bodies, which are membrane-enclosed
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Figure 1 Chemical structure of tangeretin.
Figure 2 Morphological features of HL-60 cells after treatment
with tangeretin. Cells treated with 2.7 gM tangeretin for 96 h were
examined by light microscopy ( x 100). (a) Control cells. (b)
Tangeretin-treated cells. Arrows indicate the cells in apoptosis.
vesicles that have budded off the cytoplasmic extension, were
also observed. These apoptotic cells, as well as other intact
cells, excluding trypan blue dye, suggested that the cells were
not necrosing. Increased morphological characteristics of
apoptosis after incubation with tangeretin were observed in a
time-dependent manner (Figure 3). After 96 h in culture, the
percentage of apoptotic cells had increased from an average
of 2.7% in control HL-60 cells to 23.0% in cells cultured
with 27.0 jiM tangeretin.
We also examined the ability of tangeretin to induce apop-
tosis in MOLT-4 cells. MOLT-4 cells were cultured in the
presence of 0.0027-27 jAM tangeretin for 24-144 h and apop-
totic morphological changes were monitored by light micros-
copy. During the culture period, 3-5% of untreated control
cells morphologically undergo apoptosis, while almost the
same percentage of cells treated with 0.0027-27 LM tang-
eretin undergo apoptosis, and thus no significant effect of
tangeretin to promote apoptosis was observed, even after
Incubation time (h)
Figure 3 The percentage of apoptotic HL-60 cells, assessed mor-
phologically, at time points up to 96 h in the presence or absence
of 27ylM tangeretin. The values represent the average of two
different determinations. M , Control; M, tangeretin.
144 h treatment with higher concentrations of the flavonoid.
Thus, in contrast to HL-60 cells, MOLT-4 cells hardly
undergo apoptosis by tangeretin treatment in our assay
system.
Cytostatic effects of tangeretin
Tangeretin effects on growth and viability of HL-60 cells
were examined after 96 h in culture (Figure 4). Cell growth
measured by either the MTT assay method (Sargent and
Taylor, 1989) or [3H]thymidine incorporation was suppressed
by tangeretin in a dose-dependent manner; IC50 values deter-
mined by the two assay methods were 0.062 and 0.173 ItM
respectively. Cell viability assessed by a dye exclusion test,
however, was not affected by the flavonoid even in the
presence of 27 tLM tangeretin (Figure 4). In addition,
tangeretin showed little effect on the growth of cells in a
human T-lymphocytic leukaemia cell line MOLT-4. The IC50
value of tangeretin on MOLT-4 cell growth assessed by the
MTT assay was 13.0 SAM, which was 208.7 times higher than
the ICo value of the flavonoid on HL-60 cells assessed by the
same assay procedure (0.062 !LM). These tangeretin effects did
not depend on seeding densities of the leukaemic cells, since
IC50 values of tangeretin on growth of HL-60 cells seeded at
2 x I04, 1 x 105 and 1 x 106 cells ml-' and cultured with the
agent for 96 h were 0.062, 0.003, and 0.027 ,UM respectively.
Whereas, IC50 values of tangeretin on growth of MOLT-4
cells seeded at 1 x 105 and 1 x 106 cells ml-' and cultured for
96 h were 13.0 and >27 jAM respectively. To further deter-
mine whether MOLT-4 cells have a real survival advantage
over HL-60 cells, reseeding experiments in drug-free media
on HL-60 and MOLT-4 cells treated with tangeretin were
carried out (Figure 5). For these experiments, HL-60 cells or
MOLT-4 cells were seeded at cell density of 2 x 104 or
1 X 105 cells ml-' respectively and incubated for 24 h in the
absence of tangeretin. Subsequently, tangeretin was added to
each culture well to final concentration of 2.7 or 27 jAM and
the cells were cultured for 24 h in the presence of tangeretin.
After 24 h treatment with tangeretin, the cells were washed
three times to remove the agent, resuspended in fresh
medium at cell densities of 2 x 104 cells ml-' for HL-60 cells
and 1 x 105 cells ml-' for MOLT-4 cells and then cultured
for a further 96 h. After culturing, the growth of cells was
determined by the MTT assay. In this experiment, tangeretin
did not significantly affect MOLT-4 cell growth, whereas the
agent significantly inhibited HL-60 cell growth at 27 gM con-
centration as shown in Figure 5 (P<0.01). Thus, the data
supported that effects of tangeretin are specific to HL-60 cells
rather than the MOLT-4 line. No cytotoxicity or mor-
phological features of apoptosis were detected in MOLT-4
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Figure 4 Tangeretin effects on growth and viability of HL-60
cells. Maintenance and culture of HL-60 cells were carried out as
described in Materials and methods. Cells were incubated in the
presence of various concentrations (0.0027-27tiM) of tangeretin
for 96h. After termination of cell culture the cell growth was
determined by two different assay methods: MTT assay (0) and
[3H]thymidine incorporation assay (0). Cell viability was simul-
taneously examined with a dye exclusion test (0). The percen-
tages of cell growth or viability (ordinate) vs tangeretin concent-
rations (abscissa) were plotted. The results were shown as
mean ± s.e. (n = 3).
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Figure 5 Comparative study on growth of HL-60 and MOLT-4
cells treated with tangeretin after reseeding in fresh media. HL-60
cells or MOLT-4 cells were seeded at cell density of 2 x 104 or
I x I05 cells ml' respectively and incubated for 24 h in the
absence of tangeretin. Subsequently, tangeretin was added to
each culture well to a final concentration of 2.7 or 27 jAM and the
cells were cultured for 24 h in the presence of tangeretin. After
24 h treatment with tangeretin, the cells were washed three times
to remove the agent, resuspended in fresh medium at cell den-
sities of 2 x 104 cells ml-' for HL-60 cells and x 105 cells ml-'
for MOLT-4 cells and then cultured for another 96 h. After
culturing, the growth of cells was determined by the MTT assay.
cells after treatment with > 27 JtM tangeretin (data not
shown). Anti-leukaemic agents doxorubicin, vincristin and
actinomycin D inhibited growth of both HL-60 and MOLT-4
cells with IC50 values ranging from 0.002-0.024 JAM. These
agents are, however, extremely toxic to both of the cell lines,
and ICs values determined by a dye exclusion test were
0.002-0.027 JAM, which were almost the same levels as their
ICso values on cell growth. Neither of the anti-leukaemic
agents except actinomycin D (see Figure 6) induced apoptosis
in the two leukaemic cell lines in the present experimental
conditions.
Figure 6 Agarose gel electrophoresis of DNA extracted from
control HL-60 cells (lane 2), cells treated with 27 iM tangeretin
for 96 h (lane 3) and cells treated with 0.08 jiM actinomycin D for
96 h (lane 4). Lane 1, DNA size markers (Lambda phage DNA/
Hind III digest).
Effects on blastogenesis ofhuman PBMCs
Tangeretin effects on blastogenesis and cell viability of
human (PBMCs) were also examined. PBMCs were separated
from venous blood of healthy volunteers as described
previously (Hirano et al., 1989b). The cells were incubated in
the presence of 5 .g ml-' concanavalin A as a mitogen and
0.0027-27 gM tangeretin for 80 h and then pulsed with
CH]thymidine for 16h to estimate the lymphocyte growth
(blastogenesis) (Figure 7). When compared with vincristine,
the flavonoid was less effective on mitogen-stimulated blas-
togenesis of PBMCs; the IC50 value of which was 10.0 JAM or
57.8 times higher than the IC50 value of the flavonoid against
HL-60 cell growth determined by [3H]thymidine incorpora-
tion. Vincristine, in contrast, was seriously suppressive on the
blastogenesis of PBMCs, and the effect of the drug was
rather stronger than that of the immunosuppressive drug
cyclosporine (Figure 7). No cytotoxicity or morphological
features of apoptosis were detected in PBMCs after treatment
with >27 iJM tangeretin either in the presence or absence of
concanavalin A (>95% of the cells were still alive after 5
days of treatment).
Induction ofDNA fragmentation by tangeretin
DNA fragmentation is a characteristic feature of apoptosis
(Wyllie et al., 1980). Increased DNA fragmentation was ap-
parent in HL-60 cells after treatment with 2.7 JAM or more
tangeretin for 24-96 h. A typical experimental result of
agarose gel electrophoresis is shown in Figure 6, where the
effect of 27 JAM tangeretin for 96 h treatment is similar to that
of 0.08 jaM actinomycin D. Cell apoptosis from tangeretin
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Figure 7 Effects of tangeretin on the blastogenesis of PBMC.
PBMCs isolated from a healthy volunteer were stimulated with
5tig ml- concanavalin A as a mitogen in the presence of
tangeretin (0), cyclosporine (A) or vincristine (0). The blas-
togenesis (%) was estimated by measuring amounts of [3H]thy-
midine incorporated. Data are indicated as the mean ± s.e. of
triplicates in the case of tangeretin, and as the mean of duplicates
in the case of cyclosporine and vincristine.
was also confirmed by flow cytometric analysis of the DNA-
stained cells (Figure 8). Apoptotic cells with degraded DNA,
most of them located below the GI peak in the DNA histog-
ram (Figure 8, arrows), were estimated from Figure 8 to be
2.7% in control cells, while the percentage of apoptotic cells
increased to 5.4% and 23.3% after treatment with 2.7 and
27jiM tangeretin respectively, as shown in Table I. The effect
of the flavonoid on the progression of HL-60 cells through
the cell cycle is also illustrated in Figure 8 and Table I.
Exposure of cells to tangeretin resulted in a relative increase
(accumulation) of cells with S and G2/M DNA content,
which accompanied a decrease of cells with GI. This sug-
gested that the progression of the cell cycle was slowed down
at the S and/or G2/M phases with tangeretin treatment.
Modification oftangeretin effects by Ca-+, Mg2+, Zn2+ or
cycloheximide
DNA fragmentation in apoptotic cells has been reported to
be promoted by calcium-dependent endonucleases, while zinc
ions inhibit enzyme activity, which results in blocks of apop-
tosis (Duke et al., 1983). In our experiment, both calcium
and magnesium ions enhanced the growth-inhibition effects
of tangeretin (Figure 9). The IC50 value of tangeretin on cell
growth of HL-60 cells in the presence of 5 mM Ca2+ or Mg2+
was 0.008 or 0.011ILM, which was approximately 21 or 16
times lower than the ICs value of the flavonoid without
addition of divalent cations respectively. In contrast, zinc
ions significantly (25 times) attenuated the inhibitory effect of
tangeretin on HL-60 cell growth dose dependently (Figure
lOa) while zinc alone at - 50lAM showed no significant effect
on HL-60 cell growth or morphology. Moreover, 50tLM zinc
ions partially suppressed tangeretin-induced DNA fragmenta-
tion, as analysed by agarose gel electrophoresis of DNA
(Figure lOb). In Figure lOb (lane 2), a slight but apparent
DNA fragmentation could be observed in control cells, and
zinc ions also blocked this fragmentation (lane 3). It has been
reported that progression of apoptosis requires protein
biosynthesis (Bursch, 1990). Then, we examined the effect of
cycloheximide on the ability of tangeretin to suppress HL-60
cell growth (Figure 11). Cycloheximide at 5 ngml-I
significantly diminished the effect of tangeretin; the IC50 value
of the flavonoid was increased to 7.8gM, which was 45.3
times higher than the IC50 value without cycloheximide. The
concentration of cycloheximide at 5 ngml' was the max-
imum concentration which did not significantly alter growth
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Figure 8 DNA frequency histograms of HL-60 cells untreated
(a) or exposed to 2.7tM (b) or 27gM (c) tangeretin for 96 h.
Cultures exposed to the flavonoid demonstrated a loss of G, cells
and the concomitant appearance of apoptotic cells with fractional
DNA content (arrows) following staining with ethidium bromide.
or viability of the cells. Thus, the results suggest that protein
biosynthesis is at least partially required for tangeretin
induced apoptosis of HL-60 cells.
HL-60 cells have been reported to be able to differentiate
along the myeloid or monocytic lineage (Imaizumi and Breit-
man, 1987) in the presence of some inducers such as 1,25-
hydroxyvitamine D3, retinoids or phenylacetate (Samid et al.,
1992). Tangeretin, however, induced no morphological
changes in cell shape or oxidase activity which was charac-
teristic of differentiated cells (data not shown).
Taking these observations into consideration, the flavonoid
was suggested to induce Ca2+- and Mg2+- dependent
endonuclease activity, which consequently results in program-
med cell death of HL-60 cells.
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-TableI Percentage ofcellswith aDNAcontent <2N(apoptoticcells)
and in various phases ofcell cycle in HL-60 cell culture following 96 h
treatment with tangeretin
Tangeretin
Concentration Cells (%)G
(AM) Apoptotic G, S G2/M
0 2.7 54.9 27.7 17.4
2.7 5.3 49.6 37.4 13.2
27.0 23.3 40.6 37.8 21.6
aThe percentage ofcells with DNA content <2 (apoptotic cells) was
calculated based on total number ofcells by flow cytometry (see Figure
8). Estimates ofcells inparticular phases ofthe cellcycle were based on
number of cells with DNA content 2-4, excluding apoptotic cells.
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Figure 9 Enhancement by exogenously added Ca2l and Mg2" of
the cytostatic effects of tangeretin on HL-60 cells. Cells were
treated with serial concentrations (0.0027-2.7 JAM) of tangeretin
in the absence or presence of 5 mM Ca2l or Mg2" for 96 h. After
termination of cell culture, the cell growth was determined by an
MTT assay, and percentage ofcell growth as compared with each
control (without tangeretin) was plotted. Open circles show
percentage growth of cells treated with tangeretin alone. Symbols
(0) and (A) show percentage growth of cells treated with
tangeretin in the presence of Ca2+ and Mg2' respectively.
Discussion
One drawback of cytotoxic drug therapy for treatment of
malignant diseases including myelocytic leukaemia is serious
toxicity, such as myelosuppression and immunodeficiency.
Induction of programmed cell death specifically in cancer
cells without effects on the immune cell system might be of
generous benefit for cancer chemotherapy. Several intrinsic
or extrinsic stimuli including hyperthermia (Barry et al.,
1990), UV radiation (Servomaa and Rytomaa, 1990), certain
toxins (Chang et al., 1989; Barry et al., 1990), cytokines
(Wright et al., 1992), and other chemicals (Nicolaou et al.,
1993) have been reported to induce apoptosis in cancer cells,
but little is known about natural compounds of diet origin
that induce apoptosis. The data described above showed that
a pentamethoxyflavone tangeretin contained in tangerine peel
efficiently blocked proliferation of HL-60 cells in vitro, with-
out showing cytotoxicity on normal human PBMCs. Tang-
eretin effect on HL-60 cell growth appeared not to be related
to cytotoxicity according to the data of a dye exclusion test.
Anti-proliferative activity ofanti-cancer agents, in contrast, is
intrinsically parallel to the cytotoxicity as had been expected,
and therefore concomitant side-effects on immune cell
systems might be inevitable. Our results further demonstrated
that the flavonoid inhibited HL-60 cell growth via induction
of programmed cell death at relatively high concentrations,
possibly through activation of Ca2+- and Mg2+-dependent
endonuclease. The tangeretin effects might require de novo
protein synthesis through progression of the apoptotic path-
Figure 10 Modification of tangeretin effects on HL-60 cells by
zinc. (a) Suppression of HL-60 cell growth by tangeretin is
attenuated by zinc. Cells were treated with serial concentrations
(0.0027-2.7gM) of tangeretin in the absence or presence of 5, 25,
or 509M zinc sulphate for 96 h. After termination of cell culture,
the cell growth was determined by an MTT assay and percentage
ofcell growth as compared with each control (without tangeretin)
was calculated. Open columns show percentage growth of cells
treated with tangeretin in the absence of zinc sulphate (control).
Columns ( M ), ( m ) and ( _ ) show percentage growth of
cells treated with tangeretin in the presence of 5, 25, and 50 JAM
zinc respectively. Bars in each column show deviation of triplicate
experiments and the statistical differences between controls (with-
out tangeretin) and other columns were determined. *P<0.05.
(b) Gel electrophoresis of DNA extracted from HL-60 cells
treated with tangeretin in the presence or absence of zinc for
96h. Lane 1, DNA size markers; lane 2, control cells; lane 3,
control cells incubated in the presence of 501JM zinc sulphate;
lane 4, cells treated with 2.7JAM tangeretin without zinc ions; lane
5, cells treated with 2.7 JAM tangeretin in the presence of 50pM
zinc sulphate.
way. Among the various flavonoids previously examined
(Hirano et al., 1994), tangeretin induced apoptosis in HL-60
cells most efficiently, while other flavonoids including hyd-
roxyflavones, mono methoxyflavones, isoflavones, and hyd-
roxychromones did not induce apoptosis in these cells in our
assay system (data not shown).
HL-60 cells have been derived from peripheral blood
leukocytes of an adult female with acute promyelocytic
leukaemia (Collins et al., 1977). Although this cell line is not
representative of either lymphoid or epithelial malignancy,
and therefore the significance of the data may be limited to
this atypical cell line at present, HL-60 has widely been used
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Figure 11 Attenuation by cycloheximide of growth-inhibiting
effects of tangeretin. HL-60 cells were treated with 0.0027-271iM
tangeretin in the presence (0) or absence (0) of 5 ngml-I
cycloheximide for 96 h. Then the growth of the cells was deter-
mined by an MTT assay method. The percentages of cell growth
as compared with controls (without tangeretin) were plotted. The
results were shown as mean ± s.e. of triplicate experiments
(n =3). Statistically significant effects were observed at tangeretin
concentrations of 0.27-271M (*P<0.01).
for studies of anti-leukaemic agents or mechanisms of apop-
tosis (Imaizumi and Breitman, 1987; Boise et al., 1992; Hotz
et al., 1992; Gorczyca et al., 1993; Solary et al., 1993;
Traganos et al., 1993; Jarvis et al., 1994; Li et al., 1994) for
the reason that HL-60 cells easily undergo apoptosis in res-
ponse to several stimuli (Hotz et al., 1992; Gorczyca et al.,
1993; Traganos et al., 1993; Jarvis et al., 1994; Li et al.,
1994). Thus, our present results can be discussed with
reference to these previous observations, and the data also
suggest that it would be worthwhile to further elucidate this
novel flavonoid as a candidate for a non-toxic antileukaemia
agent using other types of myeloid leukaemia cell lines.
Cytostatic effects of tangeretin on HL-60 cells appeared at
relatively low concentrations (<0.27 JAM), whereas induction
of apoptosis as assessed by morphological changes and DNA
fragmentation became apparent when the cells were exposed
to 2.7 JAM or more tangeretin. These observations suggest that
suppression of cell proliferation by tangeretin may proceed
before activation of endonuclease and DNA fragmentation.
Indeed tangeretin at 27 JAM blocked cell proliferation by
58.7% at 24 h culture (data not shown), while the flavonoid
at 27 JAM induced apoptosis in only 10% of HL-60 cells at
this time point. It is possible, however, that cytostasis and
apoptosis by tangeretin may occur side by side at relatively
high concentrations of tangeretin. The examples of apoptosis
known to be induced in mammalian glands, tissues or cells
(Bursch, 1990) show that many terminally differentiated cells
undergo apoptosis. In most of these cases, the cells that
undergo apoptosis are not actively proliferating and are in
the Go or GI phases of the cell cycle. HL-60 cells have been
reported to be able to differentiate into granulocytes or
monocytes in response to several stimuli (Samid et al., 1992).
Although no apparent evidence for differentiation-inducing
effects of tangeretin on HL-60 cells could be obtained under
the present experimental conditions, the deficit in the propor-
tion of unaffected cells during the GI phase coinciding with
the appearance of apoptotic cells in cultures treated with
tangeretin suggests that GI phase cells were preferentially
undergoing apoptosis in these cultures. Flow cytometric
analysis of the treated cells also showed a possibility that the
flavonoid may partially perturb cell progression through S
and/or G2/M stage and may cause real increases of cells in
these phases of cell cycle. It is not clear from the present data
of flow cytometric analysis that the cell populations with
DNA contents less than 2N (sub G, populations) denote
apoptotic cells. However, the percentage of apoptotic cells
calculated from the data from flow cytometric analysis was
well correlated with the percentage of such cells calculated
from the data from morphological observations (Figure 3),
supporting the hypothesis that the sub GI populations are
apoptotic cells. Some recent reports have also considered
these sub G, populations as apoptotic cells (Hotz et al., 1992;
Gorczyca et al., 1993; Traganos et al., 1993). In contrast to
HL-60 cells, human T-lymphocytic leukaemia MOLT-4 cells
or normal human PBMCs hardly responded to both the
cytostatic and apoptosis-inducing actions of tangeretin, sug-
gesting that the effect of the flavonoid on HL-60 cells is
modulated by cell (tissue) type-specific factors. Data of
experiments of long-term treatment with tangeretin or
reseeding experiments in drug-free media on HL-60 and
MOLT-4 cells treated with tangeretin (Figure 5) support that
MOLT-4 cells have a real survival advantage over HL-60
cells.
The time lag for apoptosis induction may depend upon
responding cell species or upon various stimuli. For instance,
apoptosis of rat fibroblast cell lines was detectable after only
4 h of treatment with cycloheximide, whereas other treat-
ments inducing apoptosis through growth arrest required
24-48 h (Evan et al., 1992). Induction or promotion of
apoptosis in human promonocytic U937 cells by interleukin 6
has also been reported to require a time lag of 24-48 h
(Afford et al., 1992). In our present studies, apparent changes
in apoptosis of HL-60 cells were observed only after 24 h in
culture with tangeretin, whereas actinomycin D caused apop-
tosis in these cells within 6 h in culture (data not shown).
Thus, tangeretin appears to require over 24 h to be effective
in inducing apoptosis in HL-60 cells. In addition to the time
lag effect of tangeretin, the effect was only apparent in a
relatively small proportion of the cells in culture (maximum
23%). In general, the apoptotic process takes approximately
3 h to complete (Bursch, 1990). Since the induction of apop-
tosis is not synchronous throughout the culture, cells at
different stages of apoptosis might co-exist. The overall rate
of cellular destruction might be very rapid, therefore, it is
quite possible that only a minimal percentage of the cells
undergoing apoptosis could be observed at any one time
during the culture period as in the case of our present
experiments. In our assay system, actinomycin D induced
DNA fragmentation of HL-60 cells at 0.27JAM, the effect of
which was much stronger than that of tangeretin. Actino-
mycin D at this concentration, however, alternatively induced
necrotic cell death of HL-60 cells, whereas tangeretin even at
high concentrations (27 JM) did not induce characteristic
features of necrotic death, as assessed by morphology and
dye exclusion tests.
The activation of an endogenous Ca2+- and Mg2+- depen-
dent endonuclease is considered to occur in virtually all
systems in which apoptosis has been identified (Cohen and
Duke, 1984). Although the activation of the endonuclease
activity does not require gene transcription or protein syn-
thesis (Bursch, 1990), de novo synthesis or activation of many
other proteins including transglutaminase (Fesus et al., 1987),
TRPM-2 (Leger et al., 1987) and a number of proteinases
appear to be required to complete apoptosis. Consistent with
these biochemical features of apoptosis, our results strongly
suggested that both Ca2+- and Mg2+- dependent endo-
nuclease activation and de novo protein synthesis are critical
for tangeretin-induced apoptosis in HL-60 cells. The observa-
tions of Cohen and Duke (1984) in a system of thymocyte
death by glucocorticoid suggest that the protein for which
synthesis is required for cell death is part of a cytoplasm-to-
nucleus calcium transport system, and activation of the
endonuclease may be the final common pathway in many
types of apoptosis.
Tangeretin is known to occur in tangerine peel (Nelson,
1934), which is extensively used in Japan in Kampo
medicines for treatment of cancer patients. Our preliminary
HPLC data suggest that those Kampo medicines contain
some polymethoxyflavonoids including tangeretin in amounts
of 100-200 yg g' of dried extracts of mixed herbs contain-
ing tangerine peel. The mechanisms for flavonoid effects onTangeretin induces apoptosis in HL460 cells
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cancer cells in general have not been clarified so far, while
inhibition of the membrane sodium pump (Kuriki and
Racker, 1976), induction of extensive single-strand breakage
(Bissery et al., 1988), inhibition of tyrosine kinase (Akiyama
et al., 1987) and blocks of cell cycle progression (Matsukawa
et al., 1993) have been considered as possibilities. Inhibition
of carcinogenesis (Verma et al., 1988) and angiogenesis (Fot-
sis et al., 1993) are other aspects of flavonoid efficacy for
cancer treatment. From these observations, the anti-cancer
activity of the flavonoids appears not to be due to a common
mechanism. In addition to these flavonoid actions, a recent
report by Yanagihara et al. (1993) suggested that isoflavones
genistein and biochanin A, contained in soy bean diets,
suppressed both in vitro and in vivo growth of human cancer
cell lines established from the gastrointestinal tract, possibly
via induction of apoptosis in these cells. These observations,
including our present findings of tangeretin effects, suggest
that at least some flavonoids of diet origin may play an
important role in the regulation of programmed malignant
cell death. However, the activity of flavonoids in inducing
apoptosis of malignant cells appears to be limited to certain
types of the compounds, such as isoflavones or
polymethoxyflavones.
The present study, in summary, proposes for the first time,
a growth-inhibitory effect of a citrus polymethoxyflavone
tangeretin against HL-60 cells at least partially through
induction of programmed cell death with less cytotoxicity on
normal human PBMCs. In the process of tangeretin-induced
apoptosis, activation of Ca2`- and Mg2"-dependent endo-
nuclease and de novo protein synthesis might be required.
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